Moryl, M.; Palatyńska-Ulatowska, A.; Maszewska, A.; Grzejdziak, I.; Dias de Oliveira, S.; Pradebon, M.C.; Steier, L.; Różalski, A.; Poli de Figueiredo, J.A.
Benefits and Challenges of the Use of Two Novel vB_Efa29212_2e and vB_Efa29212_3e Bacteriophages in Biocontrol of the Root Canal Enterococcus faecalis Infections. J. Clin. Med. 2022, 11, 6494.
https://doi.org/10.3390/jcm11216494
AMA Style
Moryl M, Palatyńska-Ulatowska A, Maszewska A, Grzejdziak I, Dias de Oliveira S, Pradebon MC, Steier L, Różalski A, Poli de Figueiredo JA.
Benefits and Challenges of the Use of Two Novel vB_Efa29212_2e and vB_Efa29212_3e Bacteriophages in Biocontrol of the Root Canal Enterococcus faecalis Infections. Journal of Clinical Medicine. 2022; 11(21):6494.
https://doi.org/10.3390/jcm11216494
Chicago/Turabian Style
Moryl, Magdalena, Aleksandra Palatyńska-Ulatowska, Agnieszka Maszewska, Iwona Grzejdziak, Silvia Dias de Oliveira, Marieli Chitolina Pradebon, Liviu Steier, Antoni Różalski, and Jose Antonio Poli de Figueiredo.
2022. "Benefits and Challenges of the Use of Two Novel vB_Efa29212_2e and vB_Efa29212_3e Bacteriophages in Biocontrol of the Root Canal Enterococcus faecalis Infections" Journal of Clinical Medicine 11, no. 21: 6494.
https://doi.org/10.3390/jcm11216494
APA Style
Moryl, M., Palatyńska-Ulatowska, A., Maszewska, A., Grzejdziak, I., Dias de Oliveira, S., Pradebon, M. C., Steier, L., Różalski, A., & Poli de Figueiredo, J. A.
(2022). Benefits and Challenges of the Use of Two Novel vB_Efa29212_2e and vB_Efa29212_3e Bacteriophages in Biocontrol of the Root Canal Enterococcus faecalis Infections. Journal of Clinical Medicine, 11(21), 6494.
https://doi.org/10.3390/jcm11216494
